Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Angiogenix Inc.

www.angiogenix.com

Latest From Angiogenix Inc.

CliniGenetics SA

French start-up CliniGenetics SA has devised an integrated pharmacogenomics and bioinformatics technology platform to identify gene and protein targets associated with vascular diseases. The company hopes to use those targets to devise novel therapies and diagnostics.
BioPharmaceutical Europe

Angiogenix Inc.

Angiogenix believes the delivery of its novel growth factor, pleiotrophin, will lessen the need for repeated interventional procedures to treat restenosis at a fraction of the current cost of interventional (device or surgical) therapy, without the use of a permanent device or foreign graft.
BioPharmaceutical Platform Technologies

Start-Up Previews (12/01)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Permanent Contraception, features profiles of Adiana Inc., Ovion Inc. and ReVas Inc. Plus these Selected Start-Ups across Health Care: Angiogenix Inc., CellControl Biomedical Laboratories AG, Cellzome GMBH, ChemGenex Therapeutics Inc. and Praxsys Biosystems Inc.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Angiogenix Inc.
  • Senior Management
  • William Garland, PhD, CEO
    Richard Salvador, Acting Pres.
    Michael Strage, Head, Bus. Dev.
  • Contact Info
  • Angiogenix Inc.
    Phone: (650) 579-6685
    500 Airport Blvd.
    #100
    Burlingame, CA 94010
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register